(Q40441867)

20 September 2017

title

Prolonged anorexia and elevated plasma cytokine levels following myeloablative allogeneic hematopoietic cell transplant (English)

1 reference

20 September 2017

2

W M Leisenring

1 reference

20 September 2017

F R Malone

1

1 reference

20 September 2017

B E Storer

3

1 reference

20 September 2017

R Lawler

4

1 reference

20 September 2017

J M Stern

5

1 reference

20 September 2017

S N Aker

6

1 reference

20 September 2017

M E Bouvier

7

1 reference

20 September 2017

P J Martin

8

1 reference

20 September 2017

A L Batchelder

9

1 reference

20 September 2017

H G Schoch

10

1 reference

20 September 2017

G B McDonald

11

1 reference

20 September 2017

language of work or name

English

0 references

publication date

13 August 2007

1 reference

Bone Marrow Transplantation

20 September 2017

published in

1 reference

20 September 2017

volume

40

1 reference

20 September 2017

issue

8

1 reference

20 September 2017

page(s)

765-772

1 reference

Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

Recent advances in the prevention of CMV infection and disease after hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

Energy expenditure of acutely ill hospitalised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

Anorectic effects of circulating cytokines: role of the vascular blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

Tumor necrosis factor-alpha gene transfer induces cachexia and inhibits muscle regeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

Systemic Interleukin-1beta stimulates the simultaneous release of norepinephrine in the paraventricular nucleus and the median eminence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

Cancer anorexia-cachexia syndrome: cytokines and neuropeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

Pro-inflammatory and anti-inflammatory cytokine mRNA induction in the periphery and brain following intraperitoneal administration of bacterial lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

Total parenteral nutrition and bowel rest modify the metabolic response to endotoxin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

Mucosal and enterocyte IL-6 production during sepsis and endotoxemia--role of transcription factors and regulation by the stress response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

Myosin light chain kinase is involved in lipopolysaccharide-induced disruption of colonic epithelial barrier and bacterial translocation in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

Altered T-cell receptor + CD28-mediated signaling and blocked cell cycle progression in interleukin 10 and transforming growth factor-beta-treated alloreactive T cells that do not induce graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

Regulation of immune responses by TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

The Smad3 Protein Is Involved in TGF- Inhibition of Class II Transactivator and Class II MHC Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

Advances in biologic therapy for ulcerative colitis and Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

Cytokine signal transduction through a homo- or heterodimer of gp130.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

Risk Factors for Anaerobic Bloodstream Infections in Bone Marrow Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

Outcomes of antiemetic prophylaxis in children undergoing bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

7 January 2021

Nutrient support in hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

7 January 2021

Body composition changes in marrow transplant recipients receiving total parenteral nutrition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

7 January 2021

Parenteral nutrition support after bone marrow transplantation: comparison of total and partial parenteral nutrition during the early posttransplantation period

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

7 January 2021

Clinical and metabolic effects of different parenteral nutrition regimens in patients undergoing allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

7 January 2021

Nutritional support in children undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

7 January 2021

trans fatty acids and systemic inflammation in heart failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

7 January 2021

Poor oral nutrition after allogeneic stem cell transplantation correlates significantly with severe graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

7 January 2021

Gut barrier function in malnourished patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

7 January 2021

Intestinal cytokine response after gut ischemia: role of gut barrier failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

7 January 2021

Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

7 January 2021

The relationship of serum IL-6 levels to acute graft-versus-host disease and hepatorenal disease after human bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

7 January 2021

Plasma cytokines in graft vs host disease and complications following bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

7 January 2021

Prospective, randomized, controlled trial to determine the effect of early enhanced enteral nutrition on clinical outcome in mechanically ventilated patients suffering head injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

7 January 2021

Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

7 January 2021

Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

7 January 2021

Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

7 January 2021

A combination of anti-interleukin 6 murine monoclonal antibody with dexamethasone and high-dose melphalan induces high complete response rates in advanced multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1705816

1 reference

Dimensions Publication ID

20 September 2017

1000013812

0 references

1 reference